BLACK FRIDAY

ADVFN

Celebrating 25 years Est 1999-2024

Save up to 60%* for North American Extreme

1 year 40%, 2 years 40% and *3 years 60%

*Across 3 years $4354.20.64 only $1741.68

ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
40.90
-0.22%
US Tech 100
20,511.20
0.60%
S&P 500
6,040.18
0.69%
US Dollar vs CAD
1.40587
0.32%
Bitcoin
96,330.40
-0.96%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. USOTC
  6. Innovent Biologics Inc (PK) (IVBXF)

  7. Innovent Biologics Inc (PK) (IVBXF) Financials

Innovent Biologics Inc (PK)

Innovent Biologics Inc (PK) (IVBXF)

USOTC
4.85
0.00
( 0.00% )
Updated: 08:30:06
Delayed by 15 minutes

Innovent Biologics Inc (PK) Financial Summary

The current IVBXF market cap is 7.87B. The company's latest EPS is CNY -0.6335 and P/E is -7.66.

Income Statement

Year End December 30 2023 20192020202120222023
CNY (元)CNY (元)CNY (元)CNY (元)CNY (元)
Total Revenue 1.05B3.84B4.27B4.56B6.21B
Operating Income -1.78B-426.5M-2.66B-3.03B-1.58B
Net Income -1.72B-998.42M-2.73B-2.18B-1.03B

Balance Sheet

Year End December 30 2023 20192020202120222023
CNY (元)CNY (元)CNY (元)CNY (元)CNY (元)
Total Assets 7.23B11.83B16.24B17.59B20.63B
Total Liabilities 2.47B3.06B5.91B6.86B8.1B
Total Equity 4.76B8.78B10.33B10.73B12.53B

Cash Flow

Year End December 30 2023 20192020202120222023
CNY (元)CNY (元)CNY (元)CNY (元)CNY (元)
Operating -1.66B-307.69M-2.02B-1.92B147.81M
Investing -2.57B-5.18B-2.7B-1.44B-998.66M
Financing 2.11B4.91B5B2.89B2.59B

Stats and Ratios

Market Cap 7.87B
Price to Earnings Ratio -7.66
Price to Sales Ratio 1.27
Price to Cash Ratio 0.78
Price to Book Ratio 0.63
Dividend Yield -

Share Statistics

Shares Outstanding 1.62B
Average Volume (1 week) 0
Average Volume (1 Month) 2.49k
52 Week Change -11.01%
52 Week High 6.40
52 Week Low 3.83
Spread (Intraday) 0.82 (15.19%)

Company Info

Company Name Innovent Biologics Inc (PK)
Address maples corporate services limited
grand cayman KY1-1104
Website https://www.innoventbio.com
Industry drugs and proprietary-whsl (5122)
ADVFN Logo
InvestorsHub

Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved

BLACK FRIDAY

ADVFN

Celebrating 25 years Est 1999-2024

Save up to 60%* for Canadian Securities Exchange (CSE) Level 1 and 2

1 year 40%, 2 years 40% and *3 years 60%

*Across 3 years $738.72 only $295.49